Yishai Levin
@yishailevin.bsky.social
Mass spectrometrist. Passionate about clinical proteomics. Leading a great team of professionals. Views are my own. 🇮🇱 I live between the river and the sea.
https://g-incpm.weizmann.ac.il/units/deBottonProteinProfiling/about
https://g-incpm.weizmann.ac.il/units/deBottonProteinProfiling/about
Hi proteomics, many people moved to Linkedin. Just so you know..
November 22, 2025 at 8:12 AM
Hi proteomics, many people moved to Linkedin. Just so you know..
If you didn’t know, this combination is possible and works seamlessly thanks to #bruker drivers. The LC is connected to the column toaster, column is #ionopticks
November 17, 2025 at 7:54 AM
If you didn’t know, this combination is possible and works seamlessly thanks to #bruker drivers. The LC is connected to the column toaster, column is #ionopticks
I have to say this loud and clear: an average of 2.4 points per peak should be unacceptable. It means you’re measuring noise.
#hupo2025
#hupo2025
November 10, 2025 at 2:27 PM
I have to say this loud and clear: an average of 2.4 points per peak should be unacceptable. It means you’re measuring noise.
#hupo2025
#hupo2025
My 11 year old dreamt that terrorists got into out home. We hid in the security room. The kids got out from the window and the terrorists killed my wife and me. That’s how she woke up on a Saturday morning.
#nowords
#nowords
November 1, 2025 at 7:44 AM
My 11 year old dreamt that terrorists got into out home. We hid in the security room. The kids got out from the window and the terrorists killed my wife and me. That’s how she woke up on a Saturday morning.
#nowords
#nowords
Automation, automation, automation
October 28, 2025 at 9:35 AM
Automation, automation, automation
Automation, automation, automation. Can’t get enough of it
October 23, 2025 at 12:54 PM
Automation, automation, automation. Can’t get enough of it
Can you please recommend a lab label printer for vials, tubes and plates?
#teammassspec
#teammassspec
October 5, 2025 at 7:57 AM
Can you please recommend a lab label printer for vials, tubes and plates?
#teammassspec
#teammassspec
Automating S-trap micro on Andrew
September 28, 2025 at 7:58 AM
Automating S-trap micro on Andrew
Waters are using AI in very cool way for customer support.
I use the support email regularly to ask questions regarding OneLab software and 9 out 10 times the AI agent provides the answer - instantly.
I use the support email regularly to ask questions regarding OneLab software and 9 out 10 times the AI agent provides the answer - instantly.
September 25, 2025 at 12:00 PM
Waters are using AI in very cool way for customer support.
I use the support email regularly to ask questions regarding OneLab software and 9 out 10 times the AI agent provides the answer - instantly.
I use the support email regularly to ask questions regarding OneLab software and 9 out 10 times the AI agent provides the answer - instantly.
Can anyone guess what’s wrong here? #andrewalliance
September 2, 2025 at 8:23 AM
Can anyone guess what’s wrong here? #andrewalliance
If AI can recognize cells in microscopy, why not pairs of socks?? 😁 (probably if I spread them out, it would have done a better job)
August 29, 2025 at 1:59 PM
If AI can recognize cells in microscopy, why not pairs of socks?? 😁 (probably if I spread them out, it would have done a better job)
August 12, 2025 at 1:00 PM
XL-MS is not easy!
August 11, 2025 at 11:08 AM
XL-MS is not easy!
Crunching numbers. Two instances of DIANN and two FragPipe in parallel
July 22, 2025 at 6:36 AM
Crunching numbers. Two instances of DIANN and two FragPipe in parallel
In a phase 1–2 trial, the allogeneic islet cell therapy zimislecel restored islet function in 100% of 14 participants with type 1 diabetes.
✅ All showed C-peptide after infusion
✅ 83% were insulin-independent at 1 year
✅ No severe hypoglycemia; www.nejm.org/doi/full/10....
#Type1Diabetes
✅ All showed C-peptide after infusion
✅ 83% were insulin-independent at 1 year
✅ No severe hypoglycemia; www.nejm.org/doi/full/10....
#Type1Diabetes
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | NEJM
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety
and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted
a phase 1–2 study of zimisle...
www.nejm.org
June 21, 2025 at 8:43 AM
In a phase 1–2 trial, the allogeneic islet cell therapy zimislecel restored islet function in 100% of 14 participants with type 1 diabetes.
✅ All showed C-peptide after infusion
✅ 83% were insulin-independent at 1 year
✅ No severe hypoglycemia; www.nejm.org/doi/full/10....
#Type1Diabetes
✅ All showed C-peptide after infusion
✅ 83% were insulin-independent at 1 year
✅ No severe hypoglycemia; www.nejm.org/doi/full/10....
#Type1Diabetes
Comparison of two sw for library-free DIA using spike-in data (1.5, 2 &5 fold), ran on the timsTOF Pro.
June 10, 2025 at 7:05 AM
Comparison of two sw for library-free DIA using spike-in data (1.5, 2 &5 fold), ran on the timsTOF Pro.
#Glycoproteomics folks: we are looking for beta testers for a commercial glycopeptide enrichment kit. Anyone interested please DM me.
#glycotime
#glycotime
May 21, 2025 at 8:58 AM
#Glycoproteomics folks: we are looking for beta testers for a commercial glycopeptide enrichment kit. Anyone interested please DM me.
#glycotime
#glycotime
Kickoff of another advanced course in #proteomics data analysis
May 18, 2025 at 7:13 AM
Kickoff of another advanced course in #proteomics data analysis